Background: We sought to investigate the clinical impact of the use of intravascular ultrasound (IVUS) during revascularization of patients with left main (LM) disease with drug-eluting stents (DES). Whether the use of IVUS during the procedure adds a clinical benefit remains unclear. There is only one previous observational study with relevant limitations supporting the value of this strategy. Methods: We performed a patient level pooled analysis of 4 registries of patients with LM disease treated with DES. A propensity score matching method was used to obtain matched pairs of patients with and without IVUS guidance. Results: A total of 1,670 patients were included and 505 patients (30.2%) underwent PCI under IVUS guidance (IVUS group). By means of the matching method, 505 patients without the use of IVUS during PCI were selected (no-IVUS group). Survival free of cardiac death, myocardial infarction and TLR at 3 years was 88.7% in IVUS group and 83.6% in no-IVUS group (p¼0.04) for overall population and 90% and 80.7% respectively (p¼0.03) for the subgroups with distal LM lesions. The incidence of definite and probable thrombosis was significantly lower in IVUS group (0.6% vs. 2.2%; p¼0.04). Finally, IVUS resulted independent predictor for major adverse events in overall population (HR 0.70, 95% CI 0.52 -0.99; p¼0.04) and in the subgroup with distal lesions (HR 0.54, 95% CI 0.34 -0.90; p¼0.02).
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Conclusions:
The results of this nation-wide registries pooled analysis confirms the clinical benefit derived from IVUS-guided strategy in patients with LM disease undergoing PCI with DES, especially in distal lesions. Background: The very long term outcome after left main stenting (LEMANS) in comparison wit surgical revascularization remains unknown. Therefore we report a 10 year clinical follow-up of patients enrolled in the prospective, randomized LEMANS trial. Methods: We randomly assigned 105 patients with unprotected left main coronary artery stenosis (ULMCA) to percutaneous coronary intervention (PCI; 52 patients) or coronary artery bypass grafting (CABG; 53 patients). Study design, protocol and midterm results were reported previously. In the current study, the mean long term follow up was collected at 9.8 AE 1 years after baseline procedure. Data on all cause mortality were collected from all patients, whereas incidence of MACCE, which included all cause death, myocardial infarction, stroke, repeated revascularization, from 90%. Results: At ten years, the mortality was comparable between stenting group when compared to surgery (23.0% vs. 28.7% p¼0.69). Similarly, the incidence of MACCE was statistically not different to surgery (51.1 vs. 64.4%, p¼0.28), however numerically the difference was in favor of stenting. The probability of long term survival up to 14 years was comparable between PCI and CABG (74.2 vs. 67.5%, p¼0.34 HR:1.45 95%CI: 0.67-3.13), however there was a trend toward higher MACCE-free survival in the PCI group (34.7 vs 22.1%, p¼0.06, HR :1.71 95%CI: 0.97-2.99, Figure) .
Conclusions: Left main stenting offers favorable long term outcomes up to 10 years and constitutes an alternative therapy for CABG.
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Background: The present study aimed to compare the long term (5-year) safety and efficacy between the one-stent, two stent, and DK crush strategies, utilizing drugeluting stents, for unprotected left main coronary artery (ULMCA) bifurcation lesions. Methods: Between March 2004 and April 2007, 633 consecutive patients with ULMCA bifurcation lesions (232 in one-stent group and 401 in two-stent group) were prospectively enrolled. The primary endpoint was the occurrence of major adverse cardiac events (MACE), a composite of cardiac death, myocardial infarction (MI), and target vessel revascularization (TVR), at 5-year follow-up. Results: Patients in the two-stent group were classified as DK crush (n¼155) and the other two-stent techniques (culotte, T stenting, Kissing stenting and classical crush, n¼246). Forty-seven (16.8%) patients in the one-stent group crossed-over to the twostent group. The one-stent group was associated with increased incidence of MI compared to the two-stent approach (10.5% vs. 5.5%, p¼0.025). The crude rate of MACE at 5-year was 28.0% in one-stent group and 28.4% in two-stent group (p¼0.927). DK crush was associated with a significantly decreased 5-year MACE compared to other two-stent approaches or the one-stent approach (DK-crush: 14.8% vs. Other two-stent approaches: 37.0%, one-stent approach: 28.0%, p<0.001). The main benefit of DK-crush appeared to be primarily secondary to a reduction in TVR (7.7% vs. 30.5% vs. 18.1%, p<0.001). By Cox regression analyses, the non-DK crush two-stent technique, a high SYNTAX score (!33) or New Risk Stratification (NERS) score (>20), and incomplete revascularization were shown to be independent predictors of MACE at 5-year follow-up. Conclusions: With distal left main true bifurcations, the two-stent technique (excluding DK-crush) is an independent predictor of long term MACE. DK-crush is associated with more favorable long-term clinical outcomes. Confirmation of these findings is required from randomized controlled trials. www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 
